Bio Medica Laborator Stock Price Analysis and Quick Research Report. Is Bio Medica Laborator an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Bio Medica Laborator. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Bio Medica Laborator has a PE ratio of 16.5100395419298 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Bio Medica Laborator has ROA of 33.6002% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Bio Medica Laborator has a Current ratio of 1.8295.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Bio Medica Laborator has a ROE of 99.5867%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Bio Medica Laborator has a Debt to Equity ratio of 1.0191 which means that the company has low proportion of debt in its capital.

• Sales growth: Bio Medica Laborator has reported revenue growth of 150.4702% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Bio Medica Laborator for the current financial year is 40.2477274631367%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Bio Medica Laborator is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Bio Medica Laborator is Rs 7.7892. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Bio Medica Laborator in Ticker for free. Also, one can get the intrinsic value of Bio Medica Laborator by using Valuation Calculators, which are available with a Finology ONE subscription. 

Bio Medica Laborator FAQs

Q1. What is Bio Medica Laborator share price today?
Ans: The current share price of Bio Medica Laborator is Rs 128.6.

Q2. What is the market capitalisation of Bio Medica Laborator?
Ans: Bio Medica Laborator has a market capitalisation of Rs 161.71451286 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Bio Medica Laborator?
Ans: The PE ratio of Bio Medica Laborator is 16.5100395419298 and the P/B ratio of Bio Medica Laborator is 8.92070560977809, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Bio Medica Laborator share?
Ans: The 52-week high share price of Bio Medica Laborator is Rs 128.6, and the 52-week low share price of Bio Medica Laborator is Rs 101.5.

Q5. Does Bio Medica Laborator pay dividends?
Ans: Currently, Bio Medica Laborator does not pay dividends. Dividend yield of Bio Medica Laborator is around 0%.

Q6. What are the face value and book value of Bio Medica Laborator shares?
Ans: The face value of Bio Medica Laborator shares is Rs 10, while the book value per share of Bio Medica Laborator is around Rs 14.4159. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Bio Medica Laborator?
Ans: Bio Medica Laborator has a total debt of Rs 15.0144 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Bio Medica Laborator?
Ans: The ROE of Bio Medica Laborator is 99.5867% and ROCE of Bio Medica Laborator is 64.1814%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Bio Medica Laborator a good buy for the long term?
Ans: The Bio Medica Laborator long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Bio Medica Laborator undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Bio Medica Laborator appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Bio Medica Laborator’s financials?
Ans: You can review Bio Medica Laborator’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.